Drug Name: Lamzede
Indications: To treat non-central nervous system manifestations of alpha-mannosidosis.
Active Ingredient: Velmanase alfa-tycv
Company: Chiesi Farmaceutici
Approval Date: 2/16/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761278s000lbl.pdf